RIL
MAZE

Rothschild Investment LLC’s Maze Therapeutics MAZE Stock Holding History

Rothschild Investment LLC’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149 Sell
5
-15
-75% -$393 ﹤0.01% 3476
2026
Q1 		$597 Buy
20
+10
+100% +$441 ﹤0.01% 3061
2025
Q4 		$414 Hold
10
– – ﹤0.01% 2964
2025
Q3 		$259 Buy
+10
New +$169 ﹤0.01% 2976

Other funds holding MAZE

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AC
AXQ Capital Jersey City, New Jersey $920M AUM 18.71% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Rothschild Investment LLC's MAZE Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Maze Therapeutics (MAZE) stake by 75% in Q2 2026, selling an estimated $393 and leaving 5 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #3476.

Rothschild Investment LLC first reported a position in MAZE in Q3 2025 and has held it in 4 quarters since. The position peaked at $597 in Q1 2026. 28 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Rothschild Investment LLC held 5 shares of Maze Therapeutics worth $149 as of Q2 2026.
  • Rothschild Investment LLC sold 15 Maze Therapeutics shares in Q2 2026, an estimated $393.
  • Maze Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3476 holding.
  • Rothschild Investment LLC first reported a position in Maze Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Rothschild Investment LLC's Maze Therapeutics position peaked at $597 in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.